v3.26.3
Consolidated Statements of Change in Stockholders’ Deficit - USD ($)
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Non-controlling interest
Total
Balance at Jun. 30, 2024 $ 330 $ 7,024,162 $ (11,026,928) $ (4,002,436)
Balance (in Shares) at Jun. 30, 2024 3,303,333          
Conversion of convertible promissory notes into common stock upon completion of reverse recapitalization $ 170 15,408,515 15,408,685
Conversion of convertible promissory notes into common stock upon completion of reverse recapitalization (in Shares) 1,696,668          
Issuance of common stock upon completion of reverse recapitalization $ 227 (2,100,865) (2,100,638)
Issuance of common stock upon completion of reverse recapitalization (in Shares) 2,270,096          
Earnout liabilities (5,688,007) (5,688,007)
Transaction costs (893,577) (893,577)
Issuance of common stock through exercise of warrants $ 1 120,749 120,750
Issuance of common stock through exercise of warrants (in Shares) 10,500          
Cancellation of common stock held in escrow $ (50) 50
Cancellation of common stock held in escrow (in Shares) (500,000)          
Stock-based compensation expenses 815,678 815,678
Foreign currency translation (5,002) (5,002)
NET LOSS (9,020,136) (9,020,136)
Balance at Jun. 30, 2025 $ 678 14,686,705 (20,047,064) (5,002) $ (5,364,683)
Balance (in Shares) at Jun. 30, 2025 6,780,597         6,780,597
Issuance of common stock under EIP $ 26 (26)
Issuance of common stock under EIP (in Shares) 260,595          
Stock-based compensation expenses 1,261,554 1,261,554
Redemption for employee tax withholdings (13,276) (13,276)
Contribution from non-controlling interest stockholder 55 55
Foreign currency translation (11,675) (11,675)
NET LOSS (52,689,934) (4) (52,689,938)
Balance at Jun. 30, 2026 $ 704 $ 15,934,957 $ (72,736,998) $ (16,677) $ 51 $ (56,817,963)
Balance (in Shares) at Jun. 30, 2026 7,041,192         7,041,192